Evidence map›Paper›PMID 23846567›Full record

Trial reportJournal of acquired immune deficiency syndromes (1999)2014

A novel community health worker tool outperforms WHO clinical staging for assessment of antiretroviral therapy eligibility in a resource-limited setting.

Peter Macpherson, David G Lalloo, Deus Thindwa, Emily L Webb, S Bertel Squire, Geoffrey A Chipungu, Nicola Desmond, Simon D Makombe, Miriam Taegtmeyer, Augustine T Choko and 1 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of acquired immune deficiency syndromes (1999), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Peter Macpherson*Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom; †TB and HIV Group, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi; ‡Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom; §Department of Pathology and Laboratory Medical Sciences, College of Medicine, University of Malawi, Blantyre, Malawi; ‖Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, United Kingdom; and ¶HIV Department, Ministry of Health, Lilongwe, Malawi.
David G Lalloo
Deus Thindwa
Emily L Webb
S Bertel Squire
Geoffrey A Chipungu
Nicola Desmond
Simon D Makombe
Miriam Taegtmeyer
Augustine T Choko
Elizabeth L Corbett

Funding

Medical Research Council MR/K012126/1Wellcome Trust 089673Wellcome Trust 091769Wellcome Trust 100890Wellcome Trust 101113
6 · The paper itself

Abstract

The accuracy of a novel community health worker antiretroviral therapy eligibility assessment tool was examined in community members in Blantyre, Malawi. Nurses independently performed World Health Organization (WHO) staging and CD4 counts. One hundred ten (55.6%) of 198 HIV-positive participants had a CD4 count of <350 cells per cubic millimeter. The community health worker tool significantly outperformed WHO clinical staging in identifying CD4 count of <350 cells per cubic millimeter in terms of sensitivity (41% vs. 19%), positive predictive value (75% vs. 68%), negative predictive values (53% vs. 47%), and area under the receiver-operator curve (0.62 vs. 0.54; P = 0.017). Reliance on WHO staging is likely to result in missed and delayed antiretroviral therapy initiation.

Indexed as

Community Health WorkersAdultAnti-Retroviral AgentsAntiretroviral Therapy, Highly ActiveCD4 Lymphocyte CountClinical MedicineDeveloping CountriesFemaleHIV InfectionsHumansMalawiMaleMiddle AgedPredictive Value of TestsPregnancySensitivity and SpecificityAnti-Retroviral Agents

Identifiers

PMID23846567
PMCPMC3966510

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.